-
Founded in:
1997-01-23 -
Country:
China -
Address:
No. 50, Changqing Road, Liuhe County, Tonghua City, Jilin Province -
Tax NO.:
91220501125581822P -
Registered Funds:
60.09 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Bifendate |
Reduce liver damage and elevated alanine aminotransferase (ALT) caused by carbon tetrachloride; inhibit liver microsomal lipid peroxidation and the metabolic conversion of carbon tetrachloride into carbon monoxide; reduce the consumption of reduced coenzyme II and oxygen during carbon tetrachloride metabolism, and protect the structure and function of liver cell biomembrane; promote liver regeneration in mice with partial hepatectomy; have a significant inducing effect on cytochrome P450 enzyme activity, and enhance the detoxification ability of carbon tetrachloride and certain carcinogens; improve protein metabolism in some hepatitis patients, increase albumin and decrease globulin.
More
Reduce liver damage and elevated alanine aminotransferase (ALT) caused by carbon tetrachloride; inhibit liver microsomal lipid peroxidation and the metabolic conversion of carbon tetrachloride into carbon monoxide; reduce the consumption of reduced coenzyme II and oxygen during carbon tetrachloride metabolism, and protect the structure and function of liver cell biomembrane; promote liver regeneration in mice with partial hepatectomy; have a significant inducing effect on cytochrome P450 enzyme activity, and enhance the detoxification ability of carbon tetrachloride and certain carcinogens; improve protein metabolism in some hepatitis patients, increase albumin and decrease globulin. |
73536-69-3 | 12 | |
| Inosine |
It directly penetrates the cell membrane into the cell, converts into inosinic acid and adenosine triphosphate, and participates in liver cell energy metabolism and protein synthesis; it increases the activity of various enzymes (especially coenzyme A and pyruvate oxidase), activates liver function, and promotes the recovery of damaged liver.
More
It directly penetrates the cell membrane into the cell, converts into inosinic acid and adenosine triphosphate, and participates in liver cell energy metabolism and protein synthesis; it increases the activity of various enzymes (especially coenzyme A and pyruvate oxidase), activates liver function, and promotes the recovery of damaged liver. |
58-63-9 | 8 | |
| Ascorbic Acid |
Participates in the formation of antibodies and collagen, tissue repair (including certain redox reactions), metabolism of phenylalanine, tyrosine, and folic acid; promotes the utilization of iron and carbohydrates and the synthesis of fat and protein; maintains immune function.
More
Participates in the formation of antibodies and collagen, tissue repair (including certain redox reactions), metabolism of phenylalanine, tyrosine, and folic acid; promotes the utilization of iron and carbohydrates and the synthesis of fat and protein; maintains immune function. |
50-81-7 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ferrous fumarate |
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.
More
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia. |
0.2g | 141-01-5 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Methionine |
One of the essential amino acids for the human body, it provides a methyl group in the process of synthesizing choline in the body; it has a fat-removing effect similar to choline and has a significant inhibitory effect on fat accumulation in the liver.
More
One of the essential amino acids for the human body, it provides a methyl group in the process of synthesizing choline in the body; it has a fat-removing effect similar to choline and has a significant inhibitory effect on fat accumulation in the liver. |
63-68-3 | 12 | |
| Tartaric acid |
A precursor substance that supplies methyl groups and is an important component for the synthesis of choline; it has a certain inhibitory effect on the proliferation of liver collagen in the cirrhosis model.
More
A precursor substance that supplies methyl groups and is an important component for the synthesis of choline; it has a certain inhibitory effect on the proliferation of liver collagen in the cirrhosis model. |
0 | ||
| Folic acid |
A precursor substance that provides methyl groups and is an important component in the synthesis of choline.
More
A precursor substance that provides methyl groups and is an important component in the synthesis of choline. |
59-30-3 | 17 | |
| Vitamin B series |
A precursor substance that supplies methyl groups, it has a fat-driving effect and is involved in promoting the synthesis of phospholipids and lipoproteins to utilize or store intrahepatic fat.
More
A precursor substance that supplies methyl groups, it has a fat-driving effect and is involved in promoting the synthesis of phospholipids and lipoproteins to utilize or store intrahepatic fat. |
0 | ||
| Vitamin B12 |
Participates in the synthesis of choline, indirectly promoting fat metabolism and improving liver function.
More
Participates in the synthesis of choline, indirectly promoting fat metabolism and improving liver function. |
68-19-9 | 16 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| 6-Aminocaproic acid |
This product is an antifibrinolytic drug. It binds to the lysine binding sites on plasminogen and plasmin, inhibiting the binding of plasminogen to fibrin and preventing its activation, thereby inhibiting fibrinolysis; at high concentrations, it directly inhibits the activity of plasmin and achieves a hemostatic effect.
More
This product is an antifibrinolytic drug. It binds to the lysine binding sites on plasminogen and plasmin, inhibiting the binding of plasminogen to fibrin and preventing its activation, thereby inhibiting fibrinolysis; at high concentrations, it directly inhibits the activity of plasmin and achieves a hemostatic effect. |
60-32-2 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cephalexin |
By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls and inhibits or kills bacteria; when used in combination with trimethoprim, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage.
More
By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls and inhibits or kills bacteria; when used in combination with trimethoprim, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage. |
125mg | 15686-71-2 | 33 |
| Trimethoprim |
Used in combination with cephalexin, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage.
More
Used in combination with cephalexin, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage. |
25mg | 738-70-5 | 44 |